Filing Details
- Accession Number:
- 0001102993-21-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-17 18:25:46
- Reporting Period:
- 2021-02-16
- Accepted Time:
- 2021-02-17 18:25:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1102993 | Liveperson Inc | LPSN | Services-Prepackaged Software (7372) | 133861628 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1506224 | Daryl Carlough | C/O Liveperson, Inc. 475 Tenth Avenue, 5Th Floor New York NY 10018 | Svp, Global & Corp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-02-16 | 2,061 | $12.45 | 44,034 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-02-16 | 2,061 | $70.72 | 41,973 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-02-16 | 2,061 | $0.00 | 2,061 | $12.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,557 | 2028-02-16 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Number reported includes 9,987 unvested restricted stock units granted to and held by the reporting person as of the date of this filing.
- The Option is vested and exercisable with respect to 22,118 underlying shares (after taking into account prior exercises, but including the 2,061 underlying shares disposed of in this exercise) and will vest and become exercisable with respect to the remaining 17,500 underlying shares in four remaining equal installments on each of May 16, August 16 and November 16, 2021 and February 16, 2022.